International audienceThis article represents the first in a series of tutorials on model evaluation in nonlinear mixed effect models (NLMEMs), from the International Society of Pharmacometrics (ISoP) Model Evaluation Group. Numerous tools are available for evaluation of NLMEM, with a particular emphasis on visual assessment. This first basic tutorial focuses on presenting graphical evaluation tools of NLMEM for continuous data. It illustrates graphs for correct or misspecified models, discusses their pros and cons, and recalls the definition of metrics used
In drug development clinical trials are designed to investigate whether a new treatment is safe and ...
Analyses of longitudinal data with non-linear mixed-effects models (NLMEM) are typically associated ...
This paperback edition is a reprint of the 2000 edition. This book provides a comprehensive treatmen...
International audienceThis article represents the first in a series of tutorials on model evaluation...
This article represents the first in a series of tutorials on model evaluation in nonlinear mixed ef...
This article represents the first in a series of tutorials on model evaluation in nonlinear mixed ef...
International audienceThis article revisits twenty years of our work in developing evaluation tools ...
Purpose. It is often difficult to estimate parameters from individual clinical data because of noisy...
International audiencePharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-...
PURPOSE. It is often difficult to estimate parameters from indi-vidual clinical data because of nois...
International audiencePURPOSE: The aim of this study is to define and illustrate metrics for the ext...
Population PK models aim to describe the change in drug concentration over time for a specific popul...
International audienceData below the quantification limit (BQL data) are a common challenge in data ...
R markdown notebook and associated data used to produce the main figures in the paper "Developing to...
In drug development clinical trials are designed to investigate whether a new treatment is safe and ...
Analyses of longitudinal data with non-linear mixed-effects models (NLMEM) are typically associated ...
This paperback edition is a reprint of the 2000 edition. This book provides a comprehensive treatmen...
International audienceThis article represents the first in a series of tutorials on model evaluation...
This article represents the first in a series of tutorials on model evaluation in nonlinear mixed ef...
This article represents the first in a series of tutorials on model evaluation in nonlinear mixed ef...
International audienceThis article revisits twenty years of our work in developing evaluation tools ...
Purpose. It is often difficult to estimate parameters from individual clinical data because of noisy...
International audiencePharmacokinetic/pharmacodynamic data are often analysed using nonlinear mixed-...
PURPOSE. It is often difficult to estimate parameters from indi-vidual clinical data because of nois...
International audiencePURPOSE: The aim of this study is to define and illustrate metrics for the ext...
Population PK models aim to describe the change in drug concentration over time for a specific popul...
International audienceData below the quantification limit (BQL data) are a common challenge in data ...
R markdown notebook and associated data used to produce the main figures in the paper "Developing to...
In drug development clinical trials are designed to investigate whether a new treatment is safe and ...
Analyses of longitudinal data with non-linear mixed-effects models (NLMEM) are typically associated ...
This paperback edition is a reprint of the 2000 edition. This book provides a comprehensive treatmen...